CARDIA TECHNOLOGIES LIMITED: Wann Handel in D - 500 Beiträge pro Seite

[Glofre]

Hallo,
Cardia (CNN.ASX) soll demnächst in Deutschland gehandelt werden! Weiss jemand wann und wo dies der Fall ist?

Gruß Glofre



--------------------------------------------------------
CARDIA TECHNOLOGIES LIMITED 2000-02-01 ASX-SIGNAL-G

HOMEX - Brisbane

+++++++++++++++++++++++++
APPOINTMENT OF HK MYER OFFICE

Cardia has retained the services of Hiraoka K Myer Office Ltd
("HKMO") to act as its representative agent in Japan for the purposes
of promoting its Water Environmental Technology product.

This agreement is for a period of 12 months from 1 December 1999.

Cardia will pay HKMO a monthly retainer of A$1,500 for 12 months. On
success, Cardia will pay a fee to HKMO on a mutually agreed basis,
which will be negotiated when the parameters of the arrangements are
finalised.

HKMO will assist Cardia in the following ways:

* Identify specific companies who will have an interest in Cardia`s
technologies
* Provide introductions to relevant companies
* Provide market analysis and advice.

At the end of twelve months both parties will review progress and
decide whether to continue the arrangement.

INVESTOR EXCHANGE

Cardia entered into an agreement with NMD Holdings Sdn Bhd ("NMD")
for the exclusive rights to Investor Exchange in Australia with
non-exclusive world rights.

The terms and conditions of the agreement are:

1. Cardia will complete its due diligence process on the System
within 60 days from 9 December 1999.
2. Upon the completion of a satisfactory due diligence, Cardia will
issue 3,500,000 shares at 20 cents each to NMD, and/or its nominees,
for the rights.
3. NMD will ensure the connection and implementation of the System to
the ASX data feeder system and ensure that all ASX standards are met
and maintained.

The Investor Exchange System consists of two parts, the first being a
price reporting system, and the second, a broker trading system. It
is currently operating in Malaysia, running off that country`s stock
exchange, and can be viewed on www.ix.com.mv.

Its main features are:

* A real time web-based share trading system.
* The delivery of stock quotes directly from stockbroker`s screens to
investors.
* The provision of search facilities including codes, company
names, historical data, charts, investment analysis, and more.

The System was developed by Malaysian Company, Virtual Commerce SDN
Bhd ("VCSB") which holds the intellectual property rights. Dato Nik
Mohamed Din is the Chairman of VCSB and a shareholder.

NMD has the worldwide development and marketing rights to the
Investor Exchange System.

Its Chairman is also Dato Nik Mohamed Din, a former Executive Chairman
of the Kuala Lumpur Stock Exchange.

The Investor Exchange system rights acquisition is in line with
Cardia`s e-commerce strategy.

Consideration for these rights is the issue of 3,500,000 ordinary
shares. Cardia will pay development costs of not more than $300,000
separate to consulting fees of maximum of $100,000.

AGREEMENT WITH MICROBAN INTERNATIONAL LIMITED (ANTI-BACTERIAL
PROTECTION).

Cardia entered into a sales representation agreement to develop new
business opportunities in Australia for Microban anti-bacterial
products (medical and industrial purposes).

Microban International Ltd (MBI) is a USA company based in New
York which owns the intellectual property to antimicrobial fibre
technology which can be incorporated into polymers as well as
natural/synthetic rubber materials for a wide range of products. MBI
has research, manufacturing and marketing operations in the USA,
sales offices in Canada, Mexico, UK and Thailand, and marketing
facilities throughout Asia.

MAJOR FEATURES

1. Compatible with all major polymers and natural/synthetic rubbers
2. Proven 99.9% effective (independent laboratory certification)
3. Safety - oral toxicity in laboratory studies is equivalent to
common sugar substitutes
4. Already used in common household products such as toothpaste, hand
soaps, mouth rinse and shower soaps. Common consumer brands include
Colgate toothpaste, Reach toothbrush, Hasbro toys, Sainsburys,
Johnston & Johnston, Seally, Aquaglass and Multix.

The agreement with Cardia is specific to industrial and medical uses.
Further, current overseas clients of Microban include the following
brands -

* McDonald`s (playpen balls and barrier cream)
* Sketchley (workwear and uniforms)
* Charles Walker (conveyor belts)
* Herculite (staph check bedding)
* Microtek (incise grapes, equipment drapes)
* Ballard Medical (suction catheter)
* American Diagnostics (blood pressure cuffs, medical shears)
* Ethicon/Johnston & Johnston (hemia mesh)
* Zirc (dental trays)
* MedWrap (wound dressing)

Cardia`s focus will be to develop business opportunities and grow a
client base for MBI in Australia. The successful client base
established by MBI overseas gives Cardia an excellent opportunity to
seek similar clients in Australia, further developing Cardia`s
interest in environmentally beneficial/friendly technologies and
products.

KAD TECHNOLOGY

A series of small-scale trials have been conducted at Mount Morgan to
provide answers to the unpredicted technical problems encountered in
the last trials.

This test work is being analysed against established experimental
protocols. On receiving the results. Cardia will review these and
evaluate the product value and its marketability to the mining
industry.

[Glofre]

Hallo,
kann mir immer noch nicht jemand Info zu o.g. Aktie geben?

Gruß
Glofre

[Glofre]

Dann möchte ich den Rahmen etwas weiter fassen:
Kann mir jemand ein Web-Adresse geben auf der die Neu-Notierungen von Aktien in Deutschland (der nächsten Zeit) ersichtlich sind?

Danke
Glofre